{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:01:41Z","timestamp":1790179301989,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA0916704"],"award-info":[{"award-number":["2024YFA0916704"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Municipal Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2022CRD034"],"award-info":[{"award-number":["SHDC2022CRD034"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["YG2023LC03"],"award-info":[{"award-number":["YG2023LC03"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173076"],"award-info":[{"award-number":["82173076"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573737"],"award-info":[{"award-number":["82573737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jmoldx.2026.07.001","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:31:08Z","timestamp":1784676668000},"page":"783-793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Noninvasive Detection of Bladder Cancer via Urinary DNA Mutation and Methylation Profiling Using Modified Real-Time Quantitative PCR"],"prefix":"10.1016","volume":"28","author":[{"given":"Di","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8885-821X","authenticated-orcid":false,"given":"Hailong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2648-1662","authenticated-orcid":false,"given":"Fengwu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5763-0175","authenticated-orcid":false,"given":"Miaojun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4138-8076","authenticated-orcid":false,"given":"Qing","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5244-2949","authenticated-orcid":false,"given":"Zirui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5194-2087","authenticated-orcid":false,"given":"Haige","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7679","key":"10.1016\/j.jmoldx.2026.07.001_bib1","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/551S33a","article-title":"Bladder cancer","volume":"551","author":"Grayson","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jmoldx.2026.07.001_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","article-title":"EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1-3 years of maintenance bacillus Calmette-Gu\u00e9rin","volume":"69","author":"Cambier","year":"2016","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.jmoldx.2026.07.001_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000068002","article-title":"Comparison of the nuclear matrix protein 22 with voided urine cytology and BTA stat test in the diagnosis of transitional cell carcinoma of the bladder","volume":"36","author":"S\u00f6zen","year":"1999","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.jmoldx.2026.07.001_bib4","first-page":"167","article-title":"Comparison of ImmunoCyt, UroVysion, and urine cytology in detection of recurrent urothelial carcinoma: a split-sample study","volume":"117","author":"Sullivan","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2026.07.001_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ebiom.2019.05.004","article-title":"Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer","volume":"44","author":"Avogbe","year":"2019","journal-title":"eBioMedicine"},{"key":"10.1016\/j.jmoldx.2026.07.001_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13148-021-01073-x","article-title":"A urine-based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer","volume":"13","author":"Ruan","year":"2021","journal-title":"Clin Epigenet"},{"issue":"12","key":"10.1016\/j.jmoldx.2026.07.001_bib7","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1172\/JCI139597","article-title":"Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jmoldx.2026.07.001_bib8","article-title":"A urine-based liquid biopsy method for detection of upper tract urinary carcinoma","volume":"10","author":"Xu","year":"2020","journal-title":"Front Oncol"},{"issue":"15","key":"10.1016\/j.jmoldx.2026.07.001_bib9","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1158\/0008-5472.CAN-06-1182","article-title":"PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors","volume":"66","author":"L\u00f3pez-Knowles","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2026.07.001_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102643","article-title":"Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: evidence from the Golestan Cohort Study","volume":"53","author":"Hosen","year":"2020","journal-title":"EBioMedicine"},{"issue":"24","key":"10.1016\/j.jmoldx.2026.07.001_bib11","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1158\/0008-5472.CAN-13-2498","article-title":"TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine","volume":"73","author":"Kinde","year":"2013","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.jmoldx.2026.07.001_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1158\/1541-7786.MCR-16-0003","article-title":"Understanding TERT promoter mutations: a common path to immortality","volume":"14","author":"Bell","year":"2016","journal-title":"Mol Cancer Res"},{"issue":"3","key":"10.1016\/j.jmoldx.2026.07.001_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/15592294.2016.1154246","article-title":"Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer","volume":"11","author":"Kitchen","year":"2016","journal-title":"Epigenetics"},{"issue":"24","key":"10.1016\/j.jmoldx.2026.07.001_bib14","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1158\/0008-5472.CAN-19-1019","article-title":"Histone-related genes are hypermethylated in lung cancer and hypermethylated HIST1H4F could serve as a pan-cancer biomarker","volume":"79","author":"Dong","year":"2019","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.jmoldx.2026.07.001_bib15","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/15384047.2020.1833811","article-title":"A novel prognostic biomarker for muscle invasive bladder urothelial carcinoma based on 11 DNA methylation signature","volume":"21","author":"Feng","year":"2020","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"10.1016\/j.jmoldx.2026.07.001_bib16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.euf.2018.09.016","article-title":"HOXA9, PCDH17, POU4F2, and ONECUT2 as a urinary biomarker combination for the detection of bladder cancer in Chinese patients with hematuria","volume":"6","author":"Wu","year":"2020","journal-title":"Eur Urol Focus"},{"issue":"7","key":"10.1016\/j.jmoldx.2026.07.001_bib17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1089\/dna.2013.2030","article-title":"Hypermethylation of TWIST1 and NID2 in tumor tissues and voided urine in urinary bladder cancer patients","volume":"32","author":"Yegin","year":"2013","journal-title":"DNA Cell Biol"},{"issue":"5","key":"10.1016\/j.jmoldx.2026.07.001_bib18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10059-011-0229-x","article-title":"The role of vimentin as a methylation biomarker for early diagnosis of cervical cancer","volume":"31","author":"Jung","year":"2011","journal-title":"Mol Cells"},{"issue":"3","key":"10.1016\/j.jmoldx.2026.07.001_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2217\/epi-2018-0094","article-title":"A two-gene methylation signature for the diagnosis of bladder cancer in urine","volume":"11","author":"Bosschieter","year":"2019","journal-title":"Epigenomics"},{"issue":"6","key":"10.1016\/j.jmoldx.2026.07.001_bib20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1159\/000052519","article-title":"The early detection and diagnosis of bladder cancer: a critical review of the options","volume":"39","author":"Saad","year":"2001","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.jmoldx.2026.07.001_bib21","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","article-title":"Epidemiology, screening, and prevention of bladder cancer","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.jmoldx.2026.07.001_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0090-4295(02)02136-2","article-title":"Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses","volume":"61","author":"Lotan","year":"2003","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.jmoldx.2026.07.001_bib23","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.jmoldx.2026.07.001_bib24","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/bju.14673","article-title":"Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer","volume":"123","author":"D'Andrea","year":"2019","journal-title":"BJU Int"},{"issue":"7","key":"10.1016\/j.jmoldx.2026.07.001_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cncy.22152","article-title":"Diagnostic predictive value of the Bladder EpiCheck test in the follow-up of patients with non-muscle-invasive bladder cancer","volume":"127","author":"Trenti","year":"2019","journal-title":"Cancer Cytopathol"},{"issue":"5","key":"10.1016\/j.jmoldx.2026.07.001_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/cncy.22246","article-title":"Comparison of two new real-time polymerase chain reaction-based urinary markers in the follow-up of patients with non-muscle-invasive bladder cancer","volume":"128","author":"Trenti","year":"2020","journal-title":"Cancer Cytopathol"},{"issue":"4","key":"10.1016\/j.jmoldx.2026.07.001_bib27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.euo.2018.06.011","article-title":"Performance of the Bladder EpiCheck methylation test for patients under surveillance for non-muscle-invasive bladder cancer: results of a multicenter prospective blinded clinical trial","volume":"1","author":"Witjes","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.jmoldx.2026.07.001_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ctrv.2018.05.012","article-title":"Novel urinary biomarkers for the detection of bladder cancer: a systematic review","volume":"69","author":"Tan","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jmoldx.2026.07.001_bib29","doi-asserted-by":"crossref","unstructured":"Buchhalter I, Hutter B, Alioto TS, et al. A comprehensive multicenter comparison of whole genome sequencing pipelines using a uniform tumor-normal sample pair. Preprint. Posted online June 12, 2015. bioRxiv 013177. https:\/\/doi.org\/10.1101\/013177.","DOI":"10.1101\/013177"},{"key":"10.1016\/j.jmoldx.2026.07.001_bib30","article-title":"Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy","volume":"7","author":"Springer","year":"2018","journal-title":"eLife"},{"issue":"6","key":"10.1016\/j.jmoldx.2026.07.001_bib31","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1097\/JU.0000000000002135","article-title":"The diagnostic performance of Cxbladder Resolve, alone and in combination with other Cxbladder tests, in the identification and priority evaluation of patients at risk for urothelial carcinoma","volume":"206","author":"Raman","year":"2021","journal-title":"J Urol"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157826001224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157826001224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:13:09Z","timestamp":1790176389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157826001224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1525157826001224"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2026.07.001","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noninvasive Detection of Bladder Cancer via Urinary DNA Mutation and Methylation Profiling Using Modified Real-Time Quantitative PCR","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2026.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}